Neuberger Berman Group
BIIB icon

Neuberger Berman Group’s Biogen BIIB Stock Holding History

Neuberger Berman Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
11,651
+247
+2% +$45.5K ﹤0.01% 1165
2025
Q4 		$2.01M Buy
11,404
+426
+4% +$69.6K ﹤0.01% 1180
2025
Q3 		$1.54M Sell
10,978
-138
-1% -$18.7K ﹤0.01% 1230
2025
Q2 		$1.4M Buy
11,116
+4,226
+61% +$527K ﹤0.01% 1244
2025
Q1 		$943K Buy
6,890
+3,448
+100% +$493K ﹤0.01% 1338
2024
Q4 		$526K Sell
3,442
-28,657
-89% -$4.83M ﹤0.01% 1512
2024
Q3 		$6.22M Buy
32,099
+593
+2% +$124K ﹤0.01% 889
2024
Q2 		$7.3M Buy
31,506
+11,810
+60% +$2.57M 0.01% 831
2024
Q1 		$4.25M Sell
19,696
-2,697
-12% -$632K ﹤0.01% 974
2023
Q4 		$5.79M Buy
22,393
+2,266
+11% +$557K 0.01% 884
2023
Q3 		$5.17M Sell
20,127
-292,312
-94% -$78.2M ﹤0.01% 874
2023
Q2 		$89M Sell
312,439
-25
-0% -$7.44K 0.08% 300
2023
Q1 		$86.9M Buy
312,464
+10,933
+4% +$3.03M 0.08% 300
2022
Q4 		$83.5M Sell
301,531
-103,962
-26% -$29.4M 0.08% 296
2022
Q3 		$108M Buy
405,493
+193,812
+92% +$41.2M 0.11% 255
2022
Q2 		$43.2M Buy
211,681
+200,289
+1,758% +$40.9M 0.04% 462
2022
Q1 		$2.4M Buy
11,392
+490
+4% +$107K ﹤0.01% 1128
2021
Q4 		$2.06M Buy
10,902
+3,008
+38% +$773K ﹤0.01% 1184
2021
Q3 		$1.54M Sell
7,894
-16
-0.2% -$5.24K ﹤0.01% 1220
2021
Q2 		$1.98M Buy
7,910
+2,577
+48% +$781K ﹤0.01% 1183
2021
Q1 		$1.41M Buy
5,333
+468
+10% +$126K ﹤0.01% 1246
2020
Q4 		$1.16M Sell
4,865
-2,106
-30% -$543K ﹤0.01% 1223
2020
Q3 		$1.94M Sell
6,971
-2,649
-28% -$739K ﹤0.01% 1067
2020
Q2 		$2.55M Buy
9,620
+3,146
+49% +$946K ﹤0.01% 964
2020
Q1 		$2.05M Buy
6,474
+272
+4% +$82.5K ﹤0.01% 940
2019
Q4 		$1.84M Sell
6,202
-409
-6% -$113K ﹤0.01% 1046
2019
Q3 		$1.54M Sell
6,611
-1,733
-21% -$404K ﹤0.01% 1066
2019
Q2 		$1.95M Sell
8,344
-10,347
-55% -$2.39M ﹤0.01% 1039
2019
Q1 		$4.42M Buy
18,691
+112
+0.6% +$35.3K 0.01% 854
2018
Q4 		$5.59M Sell
18,579
-2,456
-12% -$784K 0.01% 830
2018
Q3 		$7.43M Buy
21,035
+583
+3% +$201K 0.01% 844
2018
Q2 		$5.94M Sell
20,452
-804
-4% -$226K 0.01% 890
2018
Q1 		$5.82M Buy
21,256
+427
+2% +$133K 0.01% 865
2017
Q4 		$6.64M Sell
20,829
-5,815
-22% -$1.87M 0.01% 833
2017
Q3 		$8.34M Sell
26,644
-1,330
-5% -$394K 0.01% 777
2017
Q2 		$7.59M Buy
27,974
+4,389
+19% +$1.16M 0.01% 795
2017
Q1 		$6.45M Buy
23,585
+1,560
+7% +$441K 0.01% 817
2016
Q4 		$6.25M Buy
22,025
+4,390
+25% +$1.3M 0.01% 829
2016
Q3 		$5.52M Buy
17,635
+3,750
+27% +$1.11M 0.01% 835
2016
Q2 		$3.36M Buy
13,885
+3,620
+35% +$954K ﹤0.01% 897
2016
Q1 		$2.67M Sell
10,265
-74
-0.7% -$19.5K ﹤0.01% 940
2015
Q4 		$3.17M Sell
10,339
-4,212
-29% -$1.21M ﹤0.01% 943
2015
Q3 		$4.25M Sell
14,551
-216,067
-94% -$71.4M 0.01% 907
2015
Q2 		$93.2M Buy
230,618
+148,386
+180% +$59.6M 0.1% 276
2015
Q1 		$34.7M Buy
82,232
+15,069
+22% +$5.94M 0.04% 520
2014
Q4 		$22.8M Buy
67,163
+58,569
+682% +$18.9M 0.02% 632
2014
Q3 		$2.84M Sell
8,594
-480
-5% -$158K ﹤0.01% 1057
2014
Q2 		$2.86M Sell
9,074
-2,226
-20% -$670K ﹤0.01% 1060
2014
Q1 		$3.46M Sell
11,300
-264,796
-96% -$84.1M ﹤0.01% 990
2013
Q4 		$77.2M Sell
276,096
-17,225
-6% -$4.46M 0.08% 354
2013
Q3 		$70.6M Sell
293,321
-197,221
-40% -$44.1M 0.08% 343
2013
Q2 		$106M Buy
+490,542
New +$105M 0.13% 237

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Neuberger Berman Group's BIIB Position: Q1 2026 in Review

Neuberger Berman Group increased its Biogen (BIIB) stake by 2.2% in Q1 2026, buying an estimated $45.5K and bringing the position to 11,651 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Neuberger Berman Group first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $108M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Neuberger Berman Group held 11,651 shares of Biogen worth $2.14M as of Q1 2026.
  • Neuberger Berman Group bought 247 Biogen shares in Q1 2026, an estimated $45.5K.
  • Biogen made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1165 holding.
  • Neuberger Berman Group first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Biogen position peaked at $108M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.